Group One Trading’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,594
Closed -$2K 6169
2019
Q4
$2K Buy
4,594
+2,600
+130% +$1.18K ﹤0.01% 4950
2019
Q3
$1K Hold
1,994
﹤0.01% 5064
2019
Q2
$2K Sell
1,994
-11,586
-85% -$10.1K ﹤0.01% 4798
2019
Q1
$13K Sell
13,580
-7,700
-36% -$8.27K ﹤0.01% 4200
2018
Q4
$18K Buy
21,280
+11,285
+113% +$22.2K ﹤0.01% 4076
2018
Q3
$28K Buy
+9,995
New +$28.5K ﹤0.01% 4278
2018
Q2
Sell
-5,386
Closed -$16K 5852
2018
Q1
$11K Buy
+5,386
New +$11.7K ﹤0.01% 4308
2017
Q3
Sell
-19,388
Closed -$40.2K 5571
2017
Q2
$43K Buy
19,388
+15,488
+397% +$37.9K ﹤0.01% 3585
2017
Q1
$11K Buy
+3,900
New +$10.7K ﹤0.01% 4107

Other funds holding SPHS

Group One Trading's SPHS Position: Q1 2020 in Review

Group One Trading sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 4,594 shares — an estimated $2K sold.

Group One Trading first reported a position in SPHS in Q1 2017 and held it in 9 quarters. The position peaked at $43K in Q2 2017. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Group One Trading reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 4,594 Sophiris Bio, Inc. shares in Q1 2020, an estimated $2K.
  • Group One Trading first reported a position in Sophiris Bio, Inc. in Q1 2017 and held it in 9 quarters.
  • Group One Trading's Sophiris Bio, Inc. position peaked at $43K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.